US Market Report for Autorefractors and Keratometers 2017 - MedCore

News provided by

May 03, 2017, 12:08 ET

NEW YORK, May 3, 2017 /PRNewswire/ -- Description
General Report Contents
- Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
- Market Drivers & Limiters for each chapter segment
- Competitive Analysis for each chapter segment
- Section on recent mergers & acquisitions

There were essentially no standalone autorefractor or keratometer devices left on the market in 2016. The value of AR/KR combination devices to clinicians is the time savings that they represent over traditional refractive devices.
Autorefractors/keratomers sales will slightly increase throughout the forecast period. The AR/KR market is a mature market with sales of replacement devices being the primary driver. Any new sales can be attributed to the natural growth expected as the elderly population increases in the United States.

Prices are expected to remain stable over the forecast period due to the maturity of the market and the high level of competition among manufacturers to win over new customers. Growth in ASP is driven by the increasing popularity of three-in-one combination devices that feature pachymetry or tonometry capabilities in addition to the standard functionality. The higher price of these units is driving growth in the overall market.

Abstract
Autorefractors (ARs), also called automated refractors, are computer-controlled routine diagnostic devices used for detecting refractive errors of the eye. They are useful in the determination of a patient's prescription for contact lenses or eye glasses. During the examination process, the patient uses one eye at a time to look into the machine at an image, which is projected onto the retina. The autorefractor adjusts the path of the light until the image that it observes on the patient's retina is in focus. The degree of correction necessary to achieve this is the basis for the patient's refractive prescription. This is an entirely automated process which does not require feedback from the patient. Cycloplegic agents are necessary to dilate the pupil, thereby eliminating a diagnostic error caused by pseudomyopia, a result of a constriction of the ciliary muscles.

Scope:
2013-2023
Read the full report: http://www.reportlinker.com/p04821708/US-Market-Report-for-Autorefractors-and-Keratometers-MedCore.html

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

http://www.reportlinker.com

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001